Squalamine improves retinal neovascularization

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1507-1512

  Higgins, Rosemary D ^a   Sanders, Raymond J ^b   Yan, Yun ^a   Zasloff, Michael ^c   Williams, Jon I ^c  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c Genaera Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SQUALAMINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EYE BLOOD FLOW; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA NEOVASCULARIZATION; RETINOPATHY; TREATMENT OUTCOME;

ANIMALS; CHOLESTANOLS; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED C57BL; ORGAN SIZE; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

EID: 0034098181     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Moore KS, Wehrli S, Roder H, et al. Squalamine: an amino sterol antibiotic from the shark. Proc Natl Acad Sci USA. 1993;90:1354-1358.
2. Sills AK, Williams JI, Tyler BM, et al. Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. Cancer Res. 1998;58:2784-2792.
3. Teicher BA, Williams JI, Takeuchi H, Ara G, Herbst RS, Buxton D. Potential of the amino-sterol squalamine in combination therapy in the rat 13762 mammary carcinoma and the murine Lewis Lung carcinoma. Anticancer Res. 1998;18:2567-2574.
4. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA., 1995;92:905-909.
5. Young TL, Anthony DC, Pierce E, Foley E, Smith LEH. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J Am Assoc Pediatr Ophthalmol Strabismus. 1997;1:105-110.
6. Rotschild T, Nandgaonkar BN, Yu K, Higgins RD. Dexamethasone reduces oxygen induced retinopathy in a mouse model. Pediatr Res. 1999;46:94-100.
7. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetate. Ophthalmology. 1996;103:2099-2104.
8. Lawas-Alejo PA, Slivka S, Hernandez H, Bry K, Hallman M. Hyperoxia and glucocorticoid modify retinal vessel growth and interleukin-1 receptor antagonist in newborn rabbits. Pediatr Res. 1999; 45:313-317.
9. Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol. 1985;103:708-711.
10. Smith LEH, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35: 101-111.
11. Higgins RD, Yu K, Sanders RJ, Nandgaonkar B, Rotschild T, Rifkin DB. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res. 1999;18:20-27.
12. Nandgaonkar BN, Rotschild T, Yu K, Higgins RD. Indomethacin improves oxygen induced retinopathy in the mouse. Pediatr Res. 1999;46:184-188.
13. D'Amato R, Wesolowski E, Smith LE. Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. Microvasc Res. 1993;46:135-142.
14. Connolly SE, Hores TA, Smith LEH, D'Amore PA. Characterization of vascular development in the mouse retina. Microvasc Res. 1988;36:275-290.